Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Analog Devices Reports Fiscal Third Quarter 2025 Financial Results

Revenue of $2.88 billion, with double-digit year-over-year growth across all end markets Operating cash flow of $4.2 billion and free cash flow of $3.7 billion on a trailing twelve-month basis or 4...

Given the $1.6 billion returned to shareholders and strong cash generation, what is the expected impact on the stock price and future capital‑allocation strategy (e.g., buybacks, dividends, M&A)? How does Analog Devices' operating cash flow and free cash flow conversion rates compare to its main competitors in the analog and mixed‑signal space? What are the key drivers behind the double‑digit year‑over‑year revenue growth across all end markets, and are they sustainable for the next quarters?
Symbol: ADI
Earnings
22 days ago
Read more prnewswire

Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare dis...

Could the accelerated FDA timeline signal a broader regulatory advantage for Rocket's pipeline, and how might that influence long‑term growth expectations? What potential upside or downside does this news create for RCKT's valuation relative to peers in the gene‑therapy space? How will the removal of the clinical hold affect Rocket Pharmaceuticals' upcoming Phase 2 trial milestones and associated cash flow forecasts?
Symbol: RCKT
Clinical trials
22 days ago
Read more businesswire

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

- Sales of rhCollagen and bioinks primed for augmentation following new U.S.-based commercial executive hire - - Raised $3.6 million in registered direct offering in second quarter - REHOVOT, Israe...

How does CollPlant's Q2 financial performance compare to analyst expectations and to its key competitors in the regenerative biotech sector? What are the intended allocations for the $3.6 million raised in the registered direct offering and how will it affect the company's cash position? How will the appointment of the new U.S.-based commercial executive influence sales momentum for rhCollagen and bioinks?
Symbol: CLGN
Earnings
22 days ago
Read more prnewswire

GoldMining Inc. Confirms Additional Significant Gold-Antimony Results Including 3.51 g/t AuEq over 93 metres (1.08 g/t Au and 0.69% Sb) in Historic Drilling at its Crucero Project, Peru

VANCOUVER, BC, Aug. 20, 2025 /PRNewswire/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE American: GLDG) is pleased to report additional strong historic drill intercepts from i...

When can investors expect an updated resource estimate or feasibility study incorporating these historic intercepts, and how might that influence the company’s valuation? What are the implications of the antimony (Sb) component for the project’s overall economics and potential metal price exposure? How will the new gold‑antimony drill results affect GoldMining’s near‑term stock price and trading volume?
Symbol: GLDG
Exploration
22 days ago
Read more prnewswire

ZIM Reports Financial Results for the Second Quarter of 2025

Reported Revenues of $1.64 Billion, Net Income of $24 million, Adjusted EBITDA1 of $472 Million and Adjusted EBIT1 of $149 Million2 Guidance Midpoints Increased: Full Year 2025 Guidance of Adjusted...

How does ZIM's Q2 2025 performance compare to its peers in the container shipping industry and what market share implications does it suggest? What are the key drivers behind the increase in full‑year adjusted EBIT guidance and are they sustainable? How will the revised 2025 adjusted EBITDA guidance affect ZIM's valuation and price target?
Symbol: ZIM
Earnings
22 days ago
Read more prnewswire

SecurityScorecard and Uniqus Consultech Announce Strategic Partnership

NEW YORK--(BUSINESS WIRE)--SecurityScorecard, the leader in Supply Chain Detection and Response (SCDR), today announced a strategic global partnership with Uniqus Consultech, a tech-enabled global ...

Are there any potential risks or integration challenges that could impact the partnership's execution and the stock's performance? What is the expected market demand for the MAX managed SCDR solutions and how might it influence the company's competitive positioning? How will the partnership between SecurityScorecard and Uniqus Consultech affect SecurityScorecard's revenue forecasts and valuation?
Symbol: SCOR
Partnership
22 days ago
Read more businesswire